1. Bjurstam N, Bjorneld L, Duffy SW. The Gothenburg Breast Screening Trial: results from 11 years follow-up. In: NIH Consensus Development Conference, Breast Cancer Screening for Women Ages 40-49, Program and Abstracts. Bethesda (MD): National Institutes of Health, 1997:63-4.
2. Andersson I. The Malmö Mammographic Screening Trial: update on results and a harm-benefit analysis. In: NIH Consensus Development Conference, Breast Cancer Screening for Women Ages 40-49, Program and Abstracts. Bethesda (MD): National Institutes of Health, 1997:51-3, and private communication.
3. Tabar L, Fagerberg G, Duffy SW. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection. In: NIH Consensus Development Conference, Breast Cancer Screening for Women Ages 40-49, Program and Abstracts. Bethesda (MD): National Institutes of Health, 1997:55-7.
4. Frisell J, Lidbrink E. The Stockholm Mammographic Screening Trial: risks and benefits. In: NIH Consensus Development Conference, Breast Cancer Screening for Women Ages 40-49, Program and Abstracts. Bethesda (MD): National Institutes of Health, 1997:59-61.
5. Nystrom L, Wall S, Rutqvist L, Andersson I, Bjurstam N, Fagerberg G, et al. Update of the overview of the Swedish Randomized Trials on breast cancer screening with mammography. In: NIH Consensus Development Conference, Breast Cancer Screening for Women Ages 40-49, Program and Abstracts. Bethesda (MD): National Institutes of Health, 1997:65-9.